Stock & Company Details
Apnimed $APMD
Price:
N/A
N/A
N/A
$759M
52 Week High:
N/A
10 Day Average Volume:
N/A
N/A
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
APMD technical indicators
Latest Apnimed (APMD) indicator readings as of 2026-10-08.
APMD's 14-day RSI is 33.8, in neutral territory. ADX reads 21.1, sitting between trending and range-bound. MACD (12, 26, 9) is -2.18, below the zero line.
Overview
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
Finance Bot
Ask your questions
Start by typing a question below.
